UMMS Affiliation
Department of Medicine
Publication Date
2021-05-10
Document Type
Article
Disciplines
Endocrine System Diseases | Internal Medicine | Nutritional and Metabolic Diseases | Primary Care | Virus Diseases
Abstract
Chronic hepatitis C (CHC) is associated with a higher risk of developing type 2 diabetes mellitus (DM). In patients with preexisting type 2 DM, CHC often worsens glycemic control. With direct-acting antivirals (DAAs)-based treatment regimens for CHC, nearly all patients achieve sustained virologic response (SVR). There is limited literature demonstrating improvement in the glycemic index of patients with DM following the eradication of hepatitis C virus (HCV) with DAA. Thus, it is reasonable to hypothesize that early treatment of CHC and optimal glycemic control in these patients could prevent chronic complications of diabetes and worsening of liver disease. We performed a retrospective cohort study examining whether HCV eradication with DAAs leads to improved glycemic index in patients with DM and the feasibility of safely and successfully offering such care at a primary care physician/providers (PCP) office.
Keywords
Hepatitis C, diabetes mellitus
Rights and Permissions
Copyright © 2021 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
DOI of Published Version
10.1080/20009666.2021.1886631
Source
Tripathi K, Loganathan S, Trivedi N, Abraham GM. Impact of hepatitis C remission on glycemic control in patients with type 2 diabetes mellitus: primary care outpatient experience. J Community Hosp Intern Med Perspect. 2021 May 10;11(3):354-356. doi: 10.1080/20009666.2021.1886631. PMID: 34234905; PMCID: PMC8118393. Link to article on publisher's site
Journal/Book/Conference Title
Journal of community hospital internal medicine perspectives
Related Resources
PubMed ID
34234905
Repository Citation
Tripathi K, Loganathan S, Trivedi N, Abraham G. (2021). Impact of hepatitis C remission on glycemic control in patients with type 2 diabetes mellitus: primary care outpatient experience. Open Access Publications by UMMS Authors. https://doi.org/10.1080/20009666.2021.1886631. Retrieved from https://escholarship.umassmed.edu/oapubs/4747
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
Included in
Endocrine System Diseases Commons, Internal Medicine Commons, Nutritional and Metabolic Diseases Commons, Primary Care Commons, Virus Diseases Commons